XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Investment - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares)     129,186       129,186  
Beginning balance $ 2,052,415 $ 2,095,502 $ 2,021,934 $ 1,906,170 $ 1,868,187 $ 1,879,933 $ 2,021,934 $ 1,879,933
Net income 225,798 348,185 270,348 247,053 193,789 173,305 $ 844,331 614,147
Foreign currency adjustments (49,790) (33,596) 6,870 (12,034) (162) (7,286)    
Dividends declared (69,552) (71,506) (72,542) (68,316) (69,094) (69,606)    
Stock issued for employee benefit plans 37,028 20,886 8,904 4,346 16,594 (3,003)    
Issuance of restricted stock, net of forfeitures           0    
Stock-based compensation expense 25,811 27,929 24,606 40,812 29,161 23,989    
Repurchase of common stock $ (544,149) (334,985) (164,618) (167,231) (132,305) (129,145)    
Ending balance (in shares) 120,594           120,594  
Ending balance $ 1,677,561 $ 2,052,415 $ 2,095,502 $ 1,950,800 $ 1,906,170 $ 1,868,187 $ 1,677,561 $ 1,950,800
Dividends declared, per share (in dollars per share) $ 0.55 $ 0.55 $ 0.55 $ 0.51 $ 0.51 $ 0.51    
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (in shares) 125,116 128,011 129,186 132,135 133,243 134,298 129,186 134,298
Beginning balance $ 12,512 $ 12,801 $ 12,919 $ 13,213 $ 13,324 $ 13,430 $ 12,919 $ 13,430
Stock issued for employee benefit plans (in shares) 555 316 418 91 250 357    
Stock issued for employee benefit plans $ 56 $ 31 $ 42 $ 9 $ 25 $ 36    
Issuance of restricted stock, net of forfeitures (in shares)           (26)    
Issuance of restricted stock, net of forfeitures           $ (3)    
Stock-based compensation expense (in shares) 0 0 0 0 0 0    
Stock-based compensation expense $ 0 $ 0 $ 0 $ 0 $ 0 $ 0    
Repurchase of common stock (in shares) (5,077) (3,211) (1,593) (1,850) (1,358) (1,386)    
Repurchase of common stock $ (509) $ (320) $ (160) $ (184) $ (136) $ (139)    
Ending balance (in shares) 120,594 125,116 128,011 130,376 132,135 133,243 120,594 130,376
Ending balance $ 12,059 $ 12,512 $ 12,801 $ 13,038 $ 13,213 $ 13,324 $ 12,059 $ 13,038
Additional Paid-in Capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 709,163 680,857 673,628 597,788 568,209 566,022 673,628 566,022
Stock issued for employee benefit plans (3,478) 377 (17,377) (1,418) 418 (21,805)    
Issuance of restricted stock, net of forfeitures           3    
Stock-based compensation expense 25,811 27,929 24,606 40,812 29,161 23,989    
Ending balance 731,496 709,163 680,857 637,182 597,788 568,209 731,496 637,182
Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 5,411,346 5,134,667 4,936,861 4,601,227 4,476,532 4,372,833 4,936,861 4,372,833
Net income 225,798 348,185 270,348 247,053 193,789 173,305    
Dividends declared (69,552) (71,506) (72,542) (68,316) (69,094) (69,606)    
Ending balance 5,567,592 5,411,346 5,134,667 4,779,964 4,601,227 4,476,532 5,567,592 4,779,964
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (87,860) (54,264) (61,134) (53,446) (53,284) (45,998) (61,134) (45,998)
Foreign currency adjustments (49,790) (33,596) 6,870 (12,034) (162) (7,286)    
Ending balance (137,650) (87,860) (54,264) (65,480) (53,446) (53,284) (137,650) (65,480)
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (3,992,746) (3,678,559) (3,540,340) (3,252,612) (3,136,594) (3,026,354) (3,540,340) (3,026,354)
Stock issued for employee benefit plans 40,450 20,478 26,239 5,755 16,151 18,766    
Stock-based compensation expense 0 0 0 0 0 0    
Repurchase of common stock (543,640) (334,665) (164,458) (167,047) (132,169) (129,006)    
Ending balance $ (4,495,936) $ (3,992,746) $ (3,678,559) $ (3,413,904) $ (3,252,612) $ (3,136,594) $ (4,495,936) $ (3,413,904)